Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Vis graf over relationer

Expertise

Oncology; Cancer immune therapy; Sarcoma; Malignant melanoma; Tumor infiltrating lymphocytes

Primære forskningsområder

Oncology; Sarcoma; Cancer immune therapy; Tumor infiltrating lymphocytes

Aktuel forskning

Preclinical development of tumor-infiltrating lymphocytes (TIL) based adoptive cell transfer immunotherapy (ACT) for patients with sarcoma

ACT based on infusion of autologous TILs has the ability to induce complete and durable response in some patients with advanced malignant melanoma. We believe that this approach could also be effective in sarcoma. We are investigating feasibility of expanding TILs from sarcoma specimens, as well as performing functional in vitro analyses on these TILs.

Mulige interessekonflikter

No conflicts of interest

ID: 45967375